title: Inflammatory peptides at the beginning of hemodialysis in asymptomatic patients treated or not with angiotensin I-converting inhibitors.
authors.forename: F
authors.initials: F
authors.lastname: Marceau
authors.forename: S
authors.initials: S
authors.lastname: Brochu
authors.forename: I
authors.initials: I
authors.lastname: Pelletier
authors.forename: G
authors.initials: G
authors.lastname: Drapeau
authors.forename: A
authors.initials: A
authors.lastname: Adam
authors.forename: M
authors.initials: M
authors.lastname: Lebel
mesh_terms: D000706:Anaphylatoxins / Q000032:analysis*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001920:Bradykinin / Q000097:blood*; D015926:Complement C3a / Q000032:analysis; D015936:Complement C5a / Q000032:analysis; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis
chemical_list: D000706:Anaphylatoxins; D000806:Angiotensin-Converting Enzyme Inhibitors; D015926:Complement C3a; D015936:Complement C5a; D001920:Bradykinin